IMMX – immix biopharma, inc. (US:NASDAQ)

News

Immix Biopharma (NASDAQ:IMMX) was given a new $14.00 price target on by analysts at Mizuho.
Immix Biopharma (NASDAQ:IMMX) was upgraded by analysts at Wall Street Ze
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
Immix Biopharma (NASDAQ:IMMX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Immix Biopharma (NASDAQ:IMMX) was downgraded by analysts at Wall Street
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com